跳至主要内容
临床试验/JPRN-UMIN000021554
JPRN-UMIN000021554尚未招募未知

A feasibility study of combination with oral fluoropyrimidine, oxaliplatin and trastuzumab for HER2-positive advanced or recurrent gastric cancer - A feasibility study of combination with oral fluoropyrimidine, oxaliplatin and trastuzumab for HER2-positive advanced or recurrent gastric cancer

agoya University Hospital0 个研究点目标入组 20 人开始时间: 2016年4月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. HER2 negative 2. Uncontrolled diabetes 3. Uncontrolled hypertension 4. Unstable angina pectoris 5. Synchronous cancers 6. Systemic infection requiring treatment 7. Fever above 38 degree Celsius 8. A possibility of pregnancy or during pregnancy, or lactating women 9. Continuous systemic administration of steroids 10. Resistance to trastuzumab 11. Peripheral neuropathy Grade 2 or more 12. Oxaliplatin allergy

研究者

发起方
agoya University Hospital

相似试验